HEIDI HENSON

An independent board member, is the Chief Financial Officer of Respivant Biosciences. She has held senior financial positions for several start-up companies over the past 12 years both public and private. Her previous experience includes serving as the Chief Financial Officer of Kura Oncology and Wellspring Bioscience.